Lyell Immunopharma LYEL
NASDAQ LYEL
$9.63 -0.11 (-1.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Non-Current Assets (2020 - 2026)

Updated

Lyell Immunopharma's Non-Current Assets came in at $97.61 million for Q2 2026, down 5.5% from $103.24 million a year earlier but up 17.2% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Lyell Immunopharma's Non-Current Assets was $79.11 million, down 28.9% from FY2024.

  • Non-Current Assets has declined in each of the last four years, with a five-year compound annual growth rate of -22.9% (FY2020 to FY2025).
  • Going back by year, Non-Current Assets was $111.27 million in FY2024 (-43.0%), $195.34 million in FY2023 (-31.8%), $286.27 million in FY2022 (-42.9%) and $501.12 million in FY2021 (+72.4%).
  • The five-year range for quarterly Non-Current Assets is $79.11 million (Q4 2025) to $567.19 million (Q3 2021).
  • Year-over-year, Non-Current Assets has declined for 17 consecutive quarters, with an average decline of 29.7% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Assets over five years came in Q4 2021 (growth of 72.4%), and the weakest in Q3 2025 (a decline of 52.8%).
  • Business Quant data shows LYEL's Non-Current Assets at $83.32 million (Q1 2026), $79.11 million (Q4 2025) and $79.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Lyell Immunopharma 227.89 Mn 227.89 Mn - 97.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.61 Mn
Mar 31, 2026 83.32 Mn
Dec 31, 2025 79.11 Mn
Sep 30, 2025 79.76 Mn
Jun 30, 2025 103.24 Mn
Mar 31, 2025 120.62 Mn
Dec 31, 2024 111.27 Mn
Sep 30, 2024 169.17 Mn
Jun 30, 2024 154.32 Mn
Mar 31, 2024 160.06 Mn
Dec 31, 2023 195.34 Mn
Sep 30, 2023 208.14 Mn
Jun 30, 2023 228.94 Mn
Mar 31, 2023 256.05 Mn
Dec 31, 2022 286.27 Mn
Sep 30, 2022 317.52 Mn
Jun 30, 2022 354.90 Mn
Mar 31, 2022 446.40 Mn
Dec 31, 2021 501.12 Mn
Sep 30, 2021 567.19 Mn
API Access

Lyell Immunopharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY